Amphastar Articles
Court rules in novel False Claims Act case where one pharma firm sues another viewed by HP&M lawyer
28 April 2013
Watson temporarily restrained from marketing generic Lovenox; challenges Pfizer’s Embeda patent
10 October 2011
Sanofi prevails over Sun Pharma in Eloxatin patent suit; another generic Lovenox approved
20 September 2011
Showing 1-4 of 4 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
